Winner Historical Income Statement

300888 Stock

34.97 0.23 0.65%

Historical analysis of Winner Medical Co income statement accounts such as Net Interest Income of 73 M, Interest Income of 140.6 M or Interest Expense of 66.6 M can show how well Winner Medical Co performed in making a profits. Evaluating Winner Medical Co income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Winner Medical Co's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Winner Medical Co latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Winner Medical Co is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Winner Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Winner Income Statement Analysis

Winner Medical Co Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Winner Medical Co shareholders. The income statement also shows Winner investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Winner Medical Co Income Statement Chart

At present, Winner Medical Co's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 73 M, whereas Selling General Administrative is forecasted to decline to about 1.6 B.

Tax Provision Selling General Administrative Total Revenue Gross Profit

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Winner Medical Co generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Winner Medical Co minus its cost of goods sold. It is profit before Winner Medical Co operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Winner Medical Co's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Winner Medical Co current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Winner Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	4.0B	5.4B	4.0B	3.9B
Total Revenue	8.0B	11.4B	8.2B	7.5B

Gross Profit Total Revenue

Winner Medical Co income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Ebitda	Reconciled Depreciation
Tax Provision		0.31	0.27	0.49	0.81	0.88	0.8	0.99	0.98	0.91	0.71	0.7	0.64	1.0	0.98	0.97	0.07	0.9	0.25
Net Interest Income	0.31		0.9	0.77	0.62	0.55	-0.04	0.32	0.27	0.41	0.67	0.68	0.7	0.34	0.26	0.4	-0.6	0.53	0.83
Interest Income	0.27	0.9		0.9	0.71	0.62	-0.11	0.31	0.24	0.45	0.77	0.79	0.83	0.32	0.22	0.39	-0.78	0.57	0.93
Selling General Administrative	0.49	0.77	0.9		0.88	0.83	0.16	0.54	0.51	0.69	0.92	0.93	0.96	0.53	0.49	0.62	-0.62	0.78	0.94
Total Revenue	0.81	0.62	0.71	0.88		0.99	0.45	0.86	0.82	0.89	0.99	0.98	0.97	0.85	0.82	0.86	-0.37	0.94	0.74
Gross Profit	0.88	0.55	0.62	0.83	0.99		0.56	0.92	0.89	0.94	0.95	0.94	0.92	0.91	0.88	0.92	-0.29	0.97	0.64
Other Operating Expenses	0.8	-0.04	-0.11	0.16	0.45	0.56		0.74	0.81	0.6	0.31	0.31	0.27	0.77	0.81	0.72	0.54	0.57	-0.13
Operating Income	0.99	0.32	0.31	0.54	0.86	0.92	0.74		0.98	0.94	0.76	0.75	0.7	1.0	0.98	0.97	0.0	0.92	0.31
Net Income From Continuing Ops	0.98	0.27	0.24	0.51	0.82	0.89	0.81	0.98		0.91	0.73	0.72	0.67	0.98	1.0	0.94	0.14	0.88	0.27
Ebit	0.91	0.41	0.45	0.69	0.89	0.94	0.6	0.94	0.91		0.83	0.82	0.79	0.92	0.9	0.98	-0.24	0.99	0.51
Research Development	0.71	0.67	0.77	0.92	0.99	0.95	0.31	0.76	0.73	0.83		1.0	0.99	0.76	0.72	0.77	-0.46	0.88	0.82
Cost Of Revenue	0.7	0.68	0.79	0.93	0.98	0.94	0.31	0.75	0.72	0.82	1.0		0.99	0.75	0.71	0.76	-0.47	0.87	0.83
Total Operating Expenses	0.64	0.7	0.83	0.96	0.97	0.92	0.27	0.7	0.67	0.79	0.99	0.99		0.69	0.66	0.73	-0.52	0.85	0.87
Income Before Tax	1.0	0.34	0.32	0.53	0.85	0.91	0.77	1.0	0.98	0.92	0.76	0.75	0.69		0.98	0.96	0.03	0.91	0.3
Net Income	0.98	0.26	0.22	0.49	0.82	0.88	0.81	0.98	1.0	0.9	0.72	0.71	0.66	0.98		0.94	0.16	0.88	0.26
Income Tax Expense	0.97	0.4	0.39	0.62	0.86	0.92	0.72	0.97	0.94	0.98	0.77	0.76	0.73	0.96	0.94		-0.11	0.97	0.41
Minority Interest	0.07	-0.6	-0.78	-0.62	-0.37	-0.29	0.54	0.0	0.14	-0.24	-0.46	-0.47	-0.52	0.03	0.16	-0.11		-0.31	-0.76
Ebitda	0.9	0.53	0.57	0.78	0.94	0.97	0.57	0.92	0.88	0.99	0.88	0.87	0.85	0.91	0.88	0.97	-0.31		0.61
Reconciled Depreciation	0.25	0.83	0.93	0.94	0.74	0.64	-0.13	0.31	0.27	0.51	0.82	0.83	0.87	0.3	0.26	0.41	-0.76	0.61

Click cells to compare fundamentals

Winner Medical Co Account Relationship Matchups

Winner Medical Co income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	91.2M	679.9M	225.3M	245.3M	121.3M	222.6M
Net Interest Income	(19.6M)	20.8M	106.9M	70.5M	69.5M	73.0M
Interest Income	9.1M	26.2M	138.0M	123.9M	133.9M	140.6M
Interest Expense	24.9M	3.6M	30.0M	50.0M	63.4M	66.6M
Selling General Administrative	1.2B	1.7B	2.1B	2.2B	2.4B	1.6B
Total Revenue	4.6B	12.5B	8.0B	11.4B	8.2B	7.5B
Gross Profit	2.4B	7.5B	4.0B	5.4B	4.0B	3.9B
Other Operating Expenses	39.6M	116.6M	65.4M	13.7M	15.8M	15.0M
Operating Income	637.2M	5.0B	1.3B	2.2B	938.9M	1.6B
Net Income From Continuing Ops	547.2M	3.8B	1.2B	1.7B	628.5M	597.1M
Ebit	594.0M	4.8B	1.1B	2.2B	2.5B	1.6B
Research Development	155.2M	411.4M	298.2M	487.6M	322.1M	266.8M
Cost Of Revenue	2.2B	5.1B	4.0B	6.0B	4.2B	3.7B
Total Operating Expenses	3.9B	7.5B	6.7B	9.2B	7.2B	5.9B
Income Before Tax	638.4M	4.5B	1.5B	1.9B	749.8M	1.5B
Net Income Applicable To Common Shares	546.3M	3.8B	1.2B	1.7B	1.9B	1.3B
Net Income	546.3M	3.8B	1.2B	1.7B	580.4M	551.4M
Income Tax Expense	91.2M	679.9M	225.3M	245.3M	282.1M	235.4M
Minority Interest	3.2M	14.5M	1.9M	(23.6M)	(48.1M)	(45.7M)
Ebitda	766.7M	4.7B	1.9B	2.5B	2.8B	2.0B
Reconciled Depreciation	103.4M	158.6M	376.7M	481.7M	540.4M	288.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Winner Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Winner Historical Income Statement

About Winner Income Statement Analysis

Winner Medical Co Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

Winner Medical Co income statement Correlations

Winner Medical Co Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Winner Medical Co income statement Accounts

Also Currently Popular

Other Information on Investing in Winner Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Tax Provision
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Net Income From Continuing Ops
Cost Of Revenue	+ 1.0	Research Development
Operating Income	+ 0.99	Tax Provision
Gross Profit	+ 0.99	Total Revenue

Minority Interest	- 0.78	Interest Income
Reconciled Depreciation	- 0.76	Minority Interest
Minority Interest	- 0.62	Selling General Administrative
Minority Interest	- 0.6	Net Interest Income
Minority Interest	- 0.52	Total Operating Expenses
Minority Interest	- 0.47	Cost Of Revenue